Skip to main content
Year archive

Lineage Cell Therapeutics Inc. — 2020 filings

All 185 regulatory filings released by Lineage Cell Therapeutics Inc. (LCTX) in 2020, sourced directly from the official regulator.

185 Filings
2020 Period
2020 filings (185)
Filing Released Lang
Director's Dealing 2020
Director's Dealing
2020-12-31 English
LINEAGE CELL THERAPEUTICS PROVIDES END OF YEAR SHAREHOLDER LETTER
Investor Presentation
2020-12-28 English
LINEAGE CELL THERAPEUTICS PROVIDES END OF YEAR SHAREHOLDER LETTER
Report Publication Announcement
2020-12-28 English
LINEAGE CELL THERAPEUTICS TO PRESENT AT THE 13TH ANNUAL LD MICRO MAIN EVENT CONFERENCE ON DECEMBER 14, 2020
Report Publication Announcement
2020-12-09 English
LINEAGE CELL THERAPEUTICS TO PRESENT AT THE 13TH ANNUAL LD MICRO MAIN EVENT CONFERENCE ON DECEMBER 14, 2020
Regulatory Filings
2020-12-09 English
PROVIDES UPDATE ON OPC1 CELL THERAPY PROGRAM FOR THE TREATMENT OF SPINAL CORD INJURY
Regulatory Filings
2020-12-08 English
PROVIDES UPDATE ON OPC1 CELL THERAPY PROGRAM FOR THE TREATMENT OF SPINAL CORD INJURY
Report Publication Announcement
2020-12-08 English
8K:PRESENTS NEW OPREGEN® DATA FOR DRY AMD WITH GA AT 2020 AMERICAN ACADEMY OF OPHTHALMOLOGY ANNUAL MEETING
Regulatory Filings
2020-11-17 English
8K:PRESENTS NEW OPREGEN® DATA FOR DRY AMD WITH GA AT 2020 AMERICAN ACADEMY OF OPHTHALMOLOGY ANNUAL MEETING
Report Publication Announcement
2020-11-17 English
PRESENTS NEW OPREGEN® DATA FOR DRY AMD WITH GA AT 2020 AMERICAN ACADEMY OF OPHTHALMOLOGY ANNUAL MEETING
Regulatory Filings
2020-11-16 English
PRESENTS NEW OPREGEN® DATA FOR DRY AMD WITH GA AT 2020 AMERICAN ACADEMY OF OPHTHALMOLOGY ANNUAL MEETING
Report Publication Announcement
2020-11-16 English
Regulatory Filings 2020
Regulatory Filings
2020-11-16 English
SUPPORTS PATIENTS’ ACCESS TO INNOVATIVE CELL THERAPY TREATMENTS AND RESEARCH THROUGH PASSAGE OF PROPOSITION 14
Regulatory Filings
2020-11-15 English
SUPPORTS PATIENTS’ ACCESS TO INNOVATIVE CELL THERAPY TREATMENTS AND RESEARCH THROUGH PASSAGE OF PROPOSITION 14
Report Publication Announcement
2020-11-15 English
it completed enrollment in its Phase 1/2a multicenter clinical trial of OpRegen®, a retinal pigment epithelium cell transplant therapy for the treatment of advanced dry age-related macular degenerati
Regulatory Filings
2020-11-12 English
it completed enrollment in its Phase 1/2a multicenter clinical trial of OpRegen®, a retinal pigment epithelium cell transplant therapy for the treatment of advanced dry age-related macular degenerati
Report Publication Announcement
2020-11-12 English
Regulatory Filings 2020
Regulatory Filings
2020-11-12 English
COMPLETES PATIENT ENROLLMENT IN PHASE 1/2A CLINICAL STUDY OF OPREGEN® CELL THERAPY FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION
Regulatory Filings
2020-11-11 English
COMPLETES PATIENT ENROLLMENT IN PHASE 1/2A CLINICAL STUDY OF OPREGEN® CELL THERAPY FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION
Regulatory Filings
2020-11-11 English
Quarterly report for the period ending on September 30, 2020
Interim / Quarterly Report 9M 2020
2020-11-05 English
Quarterly report for the period ending on September 30, 2020
Report Publication Announcement
2020-11-05 English
REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Earnings Release Q3 2020
2020-11-05 English
REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Report Publication Announcement
2020-11-05 English
Interim / Quarterly Report 2020
Interim / Quarterly Report Q3 2020
2020-11-04 English
Regulatory Filings 2020
Regulatory Filings
2020-11-04 English
INEAGE CELL THERAPEUTICS TO HOST EXPERT CALL FOLLOWING OPREGEN® DATA UPDATE AT 2020 AMERICAN ACADEMY OF OPHTHALMOLOGY MEETING.
Regulatory Filings
2020-11-02 English
INEAGE CELL THERAPEUTICS TO HOST EXPERT CALL FOLLOWING OPREGEN® DATA UPDATE AT 2020 AMERICAN ACADEMY OF OPHTHALMOLOGY MEETING.
Report Publication Announcement
2020-11-02 English
REPORT THIRD QUARTER 2020 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE ON NOVEMBER 4, 2020
Report Publication Announcement
2020-10-28 English
REPORT THIRD QUARTER 2020 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE ON NOVEMBER 4, 2020
Report Publication Announcement
2020-10-28 English
OPREGEN DATA UPDATE TO BE FEATURED IN PRESENTATION BY CHRISTOPHER D. RIEMANN, MD AT 2020 AMERICAN ACADEMY OF OPHTHALMOLOGY MEETING
Regulatory Filings
2020-10-15 English
OPREGEN DATA UPDATE TO BE FEATURED IN PRESENTATION BY CHRISTOPHER D. RIEMANN, MD AT 2020 AMERICAN ACADEMY OF OPHTHALMOLOGY MEETING
Report Publication Announcement
2020-10-15 English
ANNOUNCE ENCOURAGING PRELIMINARY PHASE 1 STUDY RESULTS WITH VAC2 FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER
Earnings Release Q4 2020
2020-10-13 English
ANNOUNCE ENCOURAGING PRELIMINARY PHASE 1 STUDY RESULTS WITH VAC2 FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER
Regulatory Filings
2020-10-13 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Culley Brian M
Director's Dealing
2020-09-30 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Culley Brian M
Major Shareholding Notification
2020-09-30 English
Director's Dealing 2020
Director's Dealing
2020-09-30 English
Form 8-k - Results of the Company's annual meeting of shareholders.
AGM Information
2020-09-23 English
Form 8-k - Results of the Company's annual meeting of shareholders.
AGM Information
2020-09-23 English
Regulatory Filings 2020
Regulatory Filings
2020-09-23 English
LINEAGE CELL THERAPEUTICS TO PRESENT AT FORCE WEALTH VIRTUAL FIRESIDE CHAT ON SEPTEMBER 23, 2020
Regulatory Filings
2020-09-17 English
LINEAGE CELL THERAPEUTICS TO PRESENT AT FORCE WEALTH VIRTUAL FIRESIDE CHAT ON SEPTEMBER 23, 2020
Regulatory Filings
2020-09-17 English
8K:LEASE TERMINATION AGREEMENT
Regulatory Filings
2020-09-14 English
8K:LEASE TERMINATION AGREEMENT
Regulatory Filings
2020-09-14 English
Regulatory Filings 2020
Regulatory Filings
2020-09-14 English
PRESENT AT H.C. WAINWRIGHT 22ND ANNUAL GLOBAL INVESTMENT CONFERENCE ON SEPTEMBER 14, 2020 AND AT CANTOR VIRTUAL GLOBAL HEALTHCARE CONFERENCE ON SEPTEMBER 17, 2020
Regulatory Filings
2020-09-10 English
PRESENT AT H.C. WAINWRIGHT 22ND ANNUAL GLOBAL INVESTMENT CONFERENCE ON SEPTEMBER 14, 2020 AND AT CANTOR VIRTUAL GLOBAL HEALTHCARE CONFERENCE ON SEPTEMBER 17, 2020
Regulatory Filings
2020-09-10 English
LINEAGE CELL THERAPEUTICS AND AGEX THERAPEUTICS ANNOUNCE EXPANSION OF AGREEMENT RELATED TO ESI CLINICAL-GRADE PLURIPOTENT STEM CELL LINES FOR THERAPEUTIC PURPOSES
Regulatory Filings
2020-09-09 English
LINEAGE CELL THERAPEUTICS AND AGEX THERAPEUTICS ANNOUNCE EXPANSION OF AGREEMENT RELATED TO ESI CLINICAL-GRADE PLURIPOTENT STEM CELL LINES FOR THERAPEUTIC PURPOSES
Report Publication Announcement
2020-09-09 English
LINEAGE CELL THERAPEUTICS AWARDED GRANT FROM ISRAEL INNOVATION AUTHORITY FOR DEVELOPMENT OF A BIO-RETINAL PATCH FOR TREATMENT OF RETINAL DISEASES IN PARTNERSHIP WITH PRECISE BIO
Regulatory Filings
2020-09-08 English
LINEAGE CELL THERAPEUTICS AWARDED GRANT FROM ISRAEL INNOVATION AUTHORITY FOR DEVELOPMENT OF A BIO-RETINAL PATCH FOR TREATMENT OF RETINAL DISEASES IN PARTNERSHIP WITH PRECISE BIO
Report Publication Announcement
2020-09-08 English
RECEIVES $24.6 MILLION PAYMENT FROM JUVENESCENCE LTD.
Earnings Release FY 2020
2020-08-31 English
RECEIVES $24.6 MILLION PAYMENT FROM JUVENESCENCE LTD.
Regulatory Filings
2020-08-31 English
TO PRESENT AT LD MICRO 500 INVESTOR CONFERENCE AND SOLEBURY TROUT ZOOMSIDE CHAT ON SEPTEMBER 1, 2020
Regulatory Filings
2020-08-25 English
TO PRESENT AT LD MICRO 500 INVESTOR CONFERENCE AND SOLEBURY TROUT ZOOMSIDE CHAT ON SEPTEMBER 1, 2020
Regulatory Filings
2020-08-25 English
INFORMATION REQUIRED IN PROXY STATEMENT
Proxy Solicitation & Information Statement
2020-08-11 English
INFORMATION REQUIRED IN PROXY STATEMENT
Remuneration Information
2020-08-11 English
Additional materials in connection with proxy statement
Proxy Solicitation & Information Statement
2020-08-10 English
Additional materials in connection with proxy statement
Remuneration Information
2020-08-10 English
10Q: Quarterly report for the period ending on June 30, 2020
Interim / Quarterly Report Q2 2020
2020-08-09 English
10Q: Quarterly report for the period ending on June 30, 2020
Report Publication Announcement
2020-08-09 English
LINEAGE CELL THERAPEUTICS REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS AND PROVIDES UPDATE ON ALL CLINICAL PROGRAMS
Earnings Release Q2 2020
2020-08-09 English
LINEAGE CELL THERAPEUTICS REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS AND PROVIDES UPDATE ON ALL CLINICAL PROGRAMS
Report Publication Announcement Q2 2020
2020-08-09 English
Proxy Solicitation & Information Statement 2020
Proxy Solicitation & Information Statement
2020-08-08 English
Regulatory Filings 2020
Regulatory Filings
2020-08-07 English
Interim / Quarterly Report 2020
Interim / Quarterly Report Q2 2020
2020-08-06 English
Regulatory Filings 2020
Regulatory Filings
2020-08-06 English
TO REPORT SECOND QUARTER 2020 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE AND CONFERENCE CALL ON AUGUST 6, 2020
Report Publication Announcement
2020-07-30 English
TO REPORT SECOND QUARTER 2020 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE AND CONFERENCE CALL ON AUGUST 6, 2020
Report Publication Announcement
2020-07-30 English
EXTENSION OF OPREGEN® DEVELOPMENT GRANT FROM ISRAEL INNOVATION AUTHORITY
Regulatory Filings
2020-07-06 English
EXTENSION OF OPREGEN® DEVELOPMENT GRANT FROM ISRAEL INNOVATION AUTHORITY
Report Publication Announcement
2020-07-06 English
Statement of Changes in Beneficial Ownership - BAILEY DON M.
Director's Dealing
2020-07-05 English
Statement of Changes in Beneficial Ownership - BAILEY DON M.
Director's Dealing
2020-07-05 English
Statement of Changes in Beneficial Ownership - BRADSHER NEAL C.
Director's Dealing
2020-07-05 English
Statement of Changes in Beneficial Ownership - BRADSHER NEAL C.
Director's Dealing
2020-07-05 English
Statement of Changes in Beneficial Ownership - CULLEY BRIAN M.
Director's Dealing
2020-07-05 English
Statement of Changes in Beneficial Ownership - CULLEY BRIAN M.
Director's Dealing
2020-07-05 English
Statement of Changes in Beneficial Ownership - FARRELL STEPHEN C.
Director's Dealing
2020-07-05 English
Statement of Changes in Beneficial Ownership - FARRELL STEPHEN C.
Director's Dealing
2020-07-05 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Director's Dealing
2020-07-05 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Major Shareholding Notification
2020-07-05 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Director's Dealing
2020-07-05 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Major Shareholding Notification
2020-07-05 English
Statement of Changes in Beneficial Ownership - KINGSLEY ALFRED D
Director's Dealing
2020-07-05 English
Statement of Changes in Beneficial Ownership - KINGSLEY ALFRED D
Director's Dealing
2020-07-05 English
FORM 4 - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Director's Dealing
2020-07-05 English
FORM 4 - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Director's Dealing
2020-07-05 English
Director's Dealing 2020
Director's Dealing
2020-07-02 English
Director's Dealing 2020
Director's Dealing
2020-07-02 English
Director's Dealing 2020
Director's Dealing
2020-07-02 English
Director's Dealing 2020
Director's Dealing
2020-07-02 English
Director's Dealing 2020
Director's Dealing
2020-07-02 English
Director's Dealing 2020
Director's Dealing
2020-07-02 English
Director's Dealing 2020
Director's Dealing
2020-07-02 English
Director's Dealing 2020
Director's Dealing
2020-07-02 English
LINEAGE CELL THERAPEUTICS PROVIDES UPDATE ON OPC1 CELL THERAPY PROGRAM FOR SPINAL CORD INJURY
Regulatory Filings
2020-06-25 English
LINEAGE CELL THERAPEUTICS PROVIDES UPDATE ON OPC1 CELL THERAPY PROGRAM FOR SPINAL CORD INJURY
Report Publication Announcement
2020-06-25 English
LINEAGE CELL THERAPEUTICS TO PRESENT OPREGEN® DATA AT INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH (ISSCR) 2020 VIRTUAL ANNUAL MEETING
Investor Presentation
2020-06-24 English
LINEAGE CELL THERAPEUTICS TO PRESENT OPREGEN® DATA AT INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH (ISSCR) 2020 VIRTUAL ANNUAL MEETING
Report Publication Announcement
2020-06-24 English
REINITIATES PATIENT ENROLLMENT IN CLINICAL STUDY OF OPREGEN® FOR THE TREATMENT OF DRY AMD WITH GEOGRAPHIC ATROPHY
Earnings Release Q2 2020
2020-06-18 English
REINITIATES PATIENT ENROLLMENT IN CLINICAL STUDY OF OPREGEN® FOR THE TREATMENT OF DRY AMD WITH GEOGRAPHIC ATROPHY
Regulatory Filings
2020-06-18 English
LINEAGE CELL THERAPEUTICS TO PRESENT AT 2020 RAYMOND JAMES HUMAN HEALTH INNOVATION CONFERENCE
Regulatory Filings
2020-06-18 English
LINEAGE CELL THERAPEUTICS TO PRESENT AT 2020 RAYMOND JAMES HUMAN HEALTH INNOVATION CONFERENCE
Report Publication Announcement
2020-06-18 English
TO PRESENT AT 2020 RAYMOND JAMES HUMAN HEALTH INNOVATION CONFERENCE ON JUNE 18, 2020
Investor Presentation
2020-06-11 English
TO PRESENT AT 2020 RAYMOND JAMES HUMAN HEALTH INNOVATION CONFERENCE ON JUNE 18, 2020
Report Publication Announcement
2020-06-11 English
LINEAGE CELL THERAPEUTICS TO HOST THERAPEUTIC EXPERT CALL TODAY TO DISCUSS THE FIRST KNOWN REPORTED FINDING OF RETINAL TISSUE REGENERATION WITH OPREGEN® IN DRY AMD WITH GEOGRAPHIC ATROPHY
Regulatory Filings
2020-06-08 English
LINEAGE CELL THERAPEUTICS TO HOST THERAPEUTIC EXPERT CALL TODAY TO DISCUSS THE FIRST KNOWN REPORTED FINDING OF RETINAL TISSUE REGENERATION WITH OPREGEN® IN DRY AMD WITH GEOGRAPHIC ATROPHY
Report Publication Announcement
2020-06-08 English
LINEAGE CELL THERAPEUTICS REPORTS REGENERATION OF RETINAL TISSUE IN PATIENT TREATED WITH OPREGEN RPE CELLS FOR DRY AMD WITH GEOGRAPHIC ATROPHY
Earnings Release FY 2020
2020-06-01 English
LINEAGE CELL THERAPEUTICS REPORTS REGENERATION OF RETINAL TISSUE IN PATIENT TREATED WITH OPREGEN RPE CELLS FOR DRY AMD WITH GEOGRAPHIC ATROPHY
Report Publication Announcement
2020-06-01 English
The 2020 Annual Meeting date was moved from June 9, 2020
AGM Information
2020-05-24 English
The 2020 Annual Meeting date was moved from June 9, 2020
Regulatory Filings
2020-05-24 English
Regulatory Filings 2020
Regulatory Filings
2020-05-21 English
LINEAGE CELL THERAPEUTICS TO PARTICIPATE IN MAXIM GROUP AND M-VEST COVID-19 VIRTUAL CONFERENCE SERIES ON MAY 27, 2020
Regulatory Filings
2020-05-19 English
LINEAGE CELL THERAPEUTICS TO PARTICIPATE IN MAXIM GROUP AND M-VEST COVID-19 VIRTUAL CONFERENCE SERIES ON MAY 27, 2020
Report Publication Announcement
2020-05-19 English
LINEAGE CELL THERAPEUTICS TO PRESENT AT 2020 SOLEBURY TROUT VIRTUAL INVESTOR CONFERENCE .
Regulatory Filings
2020-05-18 English
LINEAGE CELL THERAPEUTICS TO PRESENT AT 2020 SOLEBURY TROUT VIRTUAL INVESTOR CONFERENCE .
Report Publication Announcement
2020-05-18 English
NOTICE OF EFFECTIVENESS
Regulatory Filings
2020-05-11 English
NOTICE OF EFFECTIVENESS
Report Publication Announcement
2020-05-11 English
Regulatory Filings 2020
Regulatory Filings
2020-05-11 English
Quarterly report for the period ending on March 31, 2020
Interim / Quarterly Report Q1 2020
2020-05-10 English
Quarterly report for the period ending on March 31, 2020
Report Publication Announcement Q1 2020
2020-05-10 English
reports entry into Material Definitive Agreement and First Quarter 2020 Financial Results.
Earnings Release Q1 2020
2020-05-10 English
reports entry into Material Definitive Agreement and First Quarter 2020 Financial Results.
Report Publication Announcement Q1 2020
2020-05-10 English
LINEAGE CELL THERAPEUTICS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Earnings Release Q1 2020
2020-05-08 English
LINEAGE CELL THERAPEUTICS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Earnings Release Q1 2020
2020-05-08 English
Interim / Quarterly Report 2020
Interim / Quarterly Report Q1 2020
2020-05-07 English
Regulatory Filings 2020
Regulatory Filings
2020-05-07 English
LINEAGE CELL THERAPEUTICS ANNOUNCES EARLY EXERCISE OF OPTION WITH CANCER RESEARCH UK FOR IMMUNO-ONCOLOGY CELL THERAPY PROGRAM
Regulatory Filings
2020-05-07 English
LINEAGE CELL THERAPEUTICS ANNOUNCES EARLY EXERCISE OF OPTION WITH CANCER RESEARCH UK FOR IMMUNO-ONCOLOGY CELL THERAPY PROGRAM
Report Publication Announcement
2020-05-07 English
Regulatory Filings 2020
Regulatory Filings
2020-05-06 English
Regulatory Filings 2020
Regulatory Filings
2020-05-06 English
REPORTS NEW DATA WITH OPREGEN FOR THE TREATMENT OF DRY AMD WITH GEOGRAPHIC ATROPHY
Regulatory Filings
2020-05-06 English
REPORTS NEW DATA WITH OPREGEN FOR THE TREATMENT OF DRY AMD WITH GEOGRAPHIC ATROPHY
Report Publication Announcement
2020-05-06 English
LINEAGE CELL THERAPEUTICS TO APPLY ALLOGENEIC DENDRITIC CELL THERAPY PROGRAM TO COVID-19 VACCINE DEVELOPMENT
Regulatory Filings
2020-05-05 English
LINEAGE CELL THERAPEUTICS TO APPLY ALLOGENEIC DENDRITIC CELL THERAPY PROGRAM TO COVID-19 VACCINE DEVELOPMENT
Report Publication Announcement
2020-05-05 English
FORM S-3-REGISTRATION STATEMENT
Capital/Financing Update
2020-05-03 English
FORM S-3-REGISTRATION STATEMENT
Report Publication Announcement
2020-05-03 English
Regulatory Filings 2020
Regulatory Filings
2020-05-01 English
LINEAGE CELL THERAPEUTICS TO REPORT FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE ON MAY 7, 2020
Report Publication Announcement
2020-04-30 English
LINEAGE CELL THERAPEUTICS TO REPORT FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE ON MAY 7, 2020
Regulatory Filings
2020-04-30 English
Amendment no. 1 to the annual report filed on March 12, 2020
Annual Report FY 2019
2020-04-30 English
Amendment no. 1 to the annual report filed on March 12, 2020
Report Publication Announcement
2020-04-30 English
SCHEDULE 13D - ONCOCYTE CORPORATION
Major Shareholding Notification
2020-04-30 English
SCHEDULE 13D - ONCOCYTE CORPORATION
Regulatory Filings
2020-04-30 English
Annual Report 2019
Annual Report FY 2019
2020-04-28 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-04-27 English
LINEAGE CELL THERAPEUTICS CONDUCTS SALE OF SHARES IN ONCOCYTE CORPORATION
Regulatory Filings
2020-04-24 English
LINEAGE CELL THERAPEUTICS CONDUCTS SALE OF SHARES IN ONCOCYTE CORPORATION
M&A Activity
2020-04-24 English
FORM 4-Statement of Changes in Beneficial Ownership - Culley Brian M.
Director's Dealing
2020-04-24 English
FORM 4-Statement of Changes in Beneficial Ownership - Culley Brian M.
Director's Dealing
2020-04-24 English
Director's Dealing 2020
Director's Dealing
2020-04-01 English
Statement of Changes in Beneficial Ownership - Roberts Brandi.
Director's Dealing
2020-03-22 English
Statement of Changes in Beneficial Ownership - Roberts Brandi.
Director's Dealing
2020-03-22 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-03-22 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Major Shareholding Notification
2020-03-22 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-03-22 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Major Shareholding Notification
2020-03-22 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-03-22 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-03-22 English
Director's Dealing 2020
Director's Dealing
2020-03-19 English
Director's Dealing 2020
Director's Dealing
2020-03-19 English
Director's Dealing 2020
Director's Dealing
2020-03-19 English
Director's Dealing 2020
Director's Dealing
2020-03-19 English
10K - annual financial report ended December 31, 2019
Annual Report FY 2019
2020-03-15 English
10K - annual financial report ended December 31, 2019
Report Publication Announcement
2020-03-15 English
LINEAGE CELL THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Earnings Release FY 2019
2020-03-15 English
LINEAGE CELL THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Report Publication Announcement
2020-03-15 English
Annual Report 2019
Annual Report FY 2019
2020-03-12 English
Regulatory Filings 2020
Regulatory Filings
2020-03-12 English
LINEAGE CELL THERAPEUTICS TO REPORT FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE ON MARCH 12, 2020
Report Publication Announcement
2020-03-05 English
LINEAGE CELL THERAPEUTICS TO REPORT FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE ON MARCH 12, 2020
Report Publication Announcement
2020-03-05 English
LINEAGE CELL THERAPEUTICS TO PRESENT AT BIOCOM’S 10TH ANNUAL GLOBAL LIFE SCIENCES PARTNERING CONFERENCE
Regulatory Filings
2020-02-20 English
LINEAGE CELL THERAPEUTICS TO PRESENT AT BIOCOM’S 10TH ANNUAL GLOBAL LIFE SCIENCES PARTNERING CONFERENCE
Report Publication Announcement
2020-02-20 English
PRESENT NEW DATA FROM OPREGEN® AND VISION RESTORATION PROGRAMS AT THE ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY ANNUAL MEETING (ARVO 2020)
Investor Presentation
2020-02-18 English
PRESENT NEW DATA FROM OPREGEN® AND VISION RESTORATION PROGRAMS AT THE ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY ANNUAL MEETING (ARVO 2020)
Report Publication Announcement
2020-02-18 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-14 English
Director's Dealing 2020
Director's Dealing
2020-02-14 English
LINEAGE CELL THERAPEUTICS TO PRESENT AT NOBLECON16 - NOBLE CAPITAL MARKETS' SIXTEENTH ANNUAL INVESTOR CONFERENCE
Investor Presentation
2020-02-10 English
LINEAGE CELL THERAPEUTICS TO PRESENT AT NOBLECON16 - NOBLE CAPITAL MARKETS' SIXTEENTH ANNUAL INVESTOR CONFERENCE
Report Publication Announcement
2020-02-10 English
LINEAGE PROVIDES POSITIVE UPDATE ON PHASE I/IIA CLINICAL STUDY OF OPREGEN® FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION
Earnings Release Q1 2020
2020-02-06 English
LINEAGE PROVIDES POSITIVE UPDATE ON PHASE I/IIA CLINICAL STUDY OF OPREGEN® FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION
Report Publication Announcement
2020-02-06 English
Regulatory Filings 2020
Regulatory Filings
2020-01-13 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-01-06 English
Director's Dealing 2020
Director's Dealing
2020-01-06 English
LINEAGE CELL THERAPEUTICS CONDUCTS SALE OF SHARES IN ONCOCYTE CORPORATION
Share Issue/Capital Change
2020-01-05 English
LINEAGE CELL THERAPEUTICS CONDUCTS SALE OF SHARES IN ONCOCYTE CORPORATION
M&A Activity
2020-01-05 English